Eneida R. Nemecek, M.D., M.S.
- click here
- 503 346-0640 or 877 346-0640
Dr. Nemecek is involved in research to increase the understanding of pediatric cancers and other diseases that can be treated with bone marrow transplantation. She participates in research collaborations at the local level with the OHSU Knight Cancer Institute and at the national and international level with cooperative groups such as the Children's Oncology Group, Pediatric Blood and Marrow Transplant Consortium, Bone Marrow Transplant Clinical Trials Network and the Center for International Blood and Marrow Transplant Research. A variety of clinical trials are available for bone marrow transplant patients at Doernbecher. Areas of current research include:
Summary of Current Research
"Allogeneic human mesenchymal stem cell therapy (Remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients,"
"Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: A concept elicitation study,"
"Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia,"
"Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: A prospective multicenter trial,"
"Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: Priorities of the westhafen intercontinental group,"